PMS33 COST-EFFECTIVENESS OF TOCILIZUMAB FOR THE MANAGEMENT OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE PREVIOUS DMARD THERAPY IN MEXICO
Nov 1, 2010, 00:00 AM
10.1016/S1098-3015(11)72186-6
https://www.valueinhealthjournal.com/article/S1098-3015(11)72186-6/fulltext
Section Title :
RESEARCH POSTER ABSTRACTS
Section Order :
345
First Page :
A308
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72186-6&doi=10.1016/S1098-3015(11)72186-6